What's Hot
View all perspectives
Robert B Chao, MD doctorRBC
3 years 6 months ago
Can biologics change our gut microbiome?
TNFi in IBD related SpA study
⭐️⬇️proteobacteria, ⬆️lachnospiraceae
⭐️TNFi could restore intestinal eubiosis
Abs#POS0230
#EULAR2021 @RheumNow
Robert B Chao, MD doctorRBC
3 years 6 months ago
Can we act on modifiable predictors of PsA?
⭐️Higher BMI associated with PsA progression from PsO
⭐️family history of PsA, nail pitting predicted PsA development
Abs#POS0145
#EULAR2021 @RheumNow
Dr. John Cush RheumNow
3 years 6 months ago
How to Watch EULAR 2021 with Dr. Jack Cush
Listen to RheumNow editor Dr. Jack Cush talk about how to take in all the amazing EULAR 2021 content and information this week. #EULAR2021
https://t.co/cXwUO7J9YS https://t.co/JAieLdAnyb
Dr. John Cush RheumNow
3 years 6 months ago
#EULAR2021 – Day 2 Report
During Day 2 there were great sessions devoted to RA, spondylarthritis, fatigue and more. Read our highlights.
https://t.co/NbBqPbbiUy https://t.co/1m6R9F7XWf
Dr. John Cush RheumNow
3 years 6 months ago
Is Rituximab and Belimumab the Combination to Beat Lupus? by Dr. Eric Dein (@ejdein1) #EULAR2021
On day 2 of EULAR , Dr. Michael Ehrenstein presented OP0129, a presentation on the BEAT-LUPUS trial looking at belimumab therapy after rituximab.
https://t.co/r4aNG7KR5h https://t.co/nppgRytnlr
Aurelie Najm AurelieRheumo
3 years 6 months ago
HOT🔥: thermography of hands in IA remotely collected via smartphone correlates w/ US features 0.48, p<0.01 and SJC 0.48, p<0.01), DAS28 (0.73, p<0.01), CDAI (0.84, p<0.01) and SDAI (0.82, p<0.01). A future tool for patients remote follow-up?
#OP0300 @Rheumnow #EULAR2021 https://t.co/MJLpz6eqIy
David Liew drdavidliew
3 years 6 months ago
Just a reminder: RA-ILD doesn't just happen in early disease; risk continues on long after diagnosis.
PS don't smoke if you have RA; smokers have an adj HR 1.92
PPS don't smoke if you don't want to get RA
PPPS don't smoke.
@MayoClinic POS0210 #EULAR2021 @RheumNow https://t.co/elhvJrK7B4
The Lancet Rheumatology TheLancetRheum
3 years 6 months ago
Presenting now at #EULAR2021
#COVID19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with #rituximab: a cohort study
https://t.co/QTGkiMcC2d https://t.co/DJB6GooPuJ
Eric Dein ejdein1
3 years 6 months ago
#EULAR2021. OP0293: Best disease activity measure for SLE flares?
⭐️c-SFI and SLE-DAS had best performance
⭐️SLE-DAS: easy to use for daily practice
@RheumNow https://t.co/9LJfbYxqOs
Janet Pope Janetbirdope
3 years 6 months ago
Which RA pts have high HAQ? F/U of 2 ERA cohorts [NOAR 1001 pts, #ESPOIR 767 pts] compared pts with high vs lower HAQ. DAS28 was = in 2 groups! But high HAQ occurred in older, females &⬆️fatigue OP0183 #EULAR2021 @RheumNow @eular_org
Janet Pope Janetbirdope
3 years 6 months ago
Is #JAKi better on PROs than #Adalimumab in MTX-IR pts with RA? Yes....some. RA BEAM with 4mg Bari >Adalimumab for pain, HAQ, am stiffness but = on fatigue. POS0649 @RheumNow @eular_org #EULAR2021
Poster Hall